vs
DOMO, INC.（DOMO）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
DOMO, INC.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.1倍（$79.4M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -0.5%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $1.1M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs -0.5%）
Domo股份有限公司是总部设在美国犹他州美国福克的美国云软件企业，主营人工智能、商业智能与数据可视化业务，属于SaaS（软件即服务）企业，核心产品可帮助企业各层级决策者在极少IT介入的情况下，实时获取业务数据，支撑决策开展。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
DOMO vs PBYI — 直观对比
营收规模更大
DOMO
是对方的1.1倍
$75.5M
营收增速更快
PBYI
高出28.2%
-0.5%
自由现金流更多
PBYI
多$13.3M
$1.1M
两年增速更快
PBYI
近两年复合增速
-0.5%
损益表 — Q3 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $79.4M | $75.5M |
| 净利润 | $-10.4M | — |
| 毛利率 | 74.2% | 69.3% |
| 营业利润率 | -8.7% | 22.7% |
| 净利率 | -13.1% | — |
| 营收同比 | -0.5% | 27.7% |
| 净利润同比 | 44.6% | — |
| 每股收益（稀释后） | $-0.25 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOMOPBYI
| Q4 25 | $79.4M | $75.5M | ||
| Q3 25 | $79.7M | $54.5M | ||
| Q2 25 | $80.1M | $52.4M | ||
| Q1 25 | $78.8M | $46.0M | ||
| Q4 24 | $79.8M | $59.1M | ||
| Q3 24 | $78.4M | $80.5M | ||
| Q2 24 | $80.1M | $47.1M | ||
| Q1 24 | $80.2M | $43.8M |
净利润DOMOPBYI
| Q4 25 | $-10.4M | — | ||
| Q3 25 | $-22.9M | $8.8M | ||
| Q2 25 | $-18.1M | $5.9M | ||
| Q1 25 | $-17.7M | $3.0M | ||
| Q4 24 | $-18.8M | — | ||
| Q3 24 | $-19.5M | $20.3M | ||
| Q2 24 | $-26.0M | $-4.5M | ||
| Q1 24 | $-18.7M | $-4.8M |
毛利率DOMOPBYI
| Q4 25 | 74.2% | 69.3% | ||
| Q3 25 | 74.8% | 77.7% | ||
| Q2 25 | 74.2% | 76.5% | ||
| Q1 25 | 74.4% | 77.1% | ||
| Q4 24 | 75.0% | 76.4% | ||
| Q3 24 | 74.3% | 63.9% | ||
| Q2 24 | 74.1% | 77.4% | ||
| Q1 24 | 76.3% | 75.5% |
营业利润率DOMOPBYI
| Q4 25 | -8.7% | 22.7% | ||
| Q3 25 | -9.1% | 17.6% | ||
| Q2 25 | -17.9% | 12.7% | ||
| Q1 25 | -15.6% | 8.7% | ||
| Q4 24 | -13.9% | 22.6% | ||
| Q3 24 | -18.5% | 27.4% | ||
| Q2 24 | -26.8% | -4.6% | ||
| Q1 24 | -16.6% | -5.3% |
净利率DOMOPBYI
| Q4 25 | -13.1% | — | ||
| Q3 25 | -28.8% | 16.2% | ||
| Q2 25 | -22.5% | 11.2% | ||
| Q1 25 | -22.4% | 6.5% | ||
| Q4 24 | -23.5% | — | ||
| Q3 24 | -24.9% | 25.2% | ||
| Q2 24 | -32.5% | -9.6% | ||
| Q1 24 | -23.3% | -11.0% |
每股收益（稀释后）DOMOPBYI
| Q4 25 | $-0.25 | $0.26 | ||
| Q3 25 | $-0.56 | $0.17 | ||
| Q2 25 | $-0.45 | $0.12 | ||
| Q1 25 | $-0.45 | $0.06 | ||
| Q4 24 | $-0.48 | $0.40 | ||
| Q3 24 | $-0.51 | $0.41 | ||
| Q2 24 | $-0.69 | $-0.09 | ||
| Q1 24 | $-0.51 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $97.5M |
| 总债务越低越好 | $124.2M | $22.7M |
| 股东权益账面价值 | $-191.9M | $130.3M |
| 总资产 | $201.6M | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资DOMOPBYI
| Q4 25 | — | $97.5M | ||
| Q3 25 | — | $94.4M | ||
| Q2 25 | $47.2M | $96.0M | ||
| Q1 25 | $45.3M | $93.2M | ||
| Q4 24 | — | $101.0M | ||
| Q3 24 | — | $96.7M | ||
| Q2 24 | $61.2M | $96.8M | ||
| Q1 24 | $60.9M | $107.2M |
总债务DOMOPBYI
| Q4 25 | $124.2M | $22.7M | ||
| Q3 25 | $121.9M | $34.0M | ||
| Q2 25 | $119.7M | $45.3M | ||
| Q1 25 | $117.7M | $56.7M | ||
| Q4 24 | $115.6M | $68.0M | ||
| Q3 24 | $115.2M | $79.3M | ||
| Q2 24 | $114.1M | $90.7M | ||
| Q1 24 | $113.5M | $102.0M |
股东权益DOMOPBYI
| Q4 25 | $-191.9M | $130.3M | ||
| Q3 25 | $-191.5M | $115.3M | ||
| Q2 25 | $-178.7M | $104.7M | ||
| Q1 25 | $-177.2M | $97.1M | ||
| Q4 24 | $-171.2M | $92.1M | ||
| Q3 24 | $-166.4M | $71.1M | ||
| Q2 24 | $-163.5M | $48.5M | ||
| Q1 24 | $-153.5M | $51.0M |
总资产DOMOPBYI
| Q4 25 | $201.6M | $216.3M | ||
| Q3 25 | $195.7M | $202.9M | ||
| Q2 25 | $189.7M | $194.9M | ||
| Q1 25 | $214.3M | $196.2M | ||
| Q4 24 | $190.2M | $213.3M | ||
| Q3 24 | $197.8M | $220.7M | ||
| Q2 24 | $204.4M | $205.0M | ||
| Q1 24 | $225.7M | $214.1M |
负债/权益比DOMOPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $3.4M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $1.1M | $14.4M |
| 自由现金流率自由现金流/营收 | 1.4% | 19.1% |
| 资本支出强度资本支出/营收 | 2.9% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $9.9M | $41.7M |
8季度趋势，按日历期对齐
经营现金流DOMOPBYI
| Q4 25 | $3.4M | $14.4M | ||
| Q3 25 | $3.4M | $9.7M | ||
| Q2 25 | $4.0M | $14.1M | ||
| Q1 25 | $8.9M | $3.6M | ||
| Q4 24 | $-13.7M | $15.6M | ||
| Q3 24 | $-6.2M | $11.0M | ||
| Q2 24 | $1.9M | $1.0M | ||
| Q1 24 | $5.4M | $11.2M |
自由现金流DOMOPBYI
| Q4 25 | $1.1M | $14.4M | ||
| Q3 25 | $1.0M | $9.7M | ||
| Q2 25 | $1.0M | $14.1M | ||
| Q1 25 | $6.7M | $3.6M | ||
| Q4 24 | $-16.2M | $15.6M | ||
| Q3 24 | $-8.4M | $11.0M | ||
| Q2 24 | $-625.0K | $1.0M | ||
| Q1 24 | $2.9M | — |
自由现金流率DOMOPBYI
| Q4 25 | 1.4% | 19.1% | ||
| Q3 25 | 1.3% | 17.7% | ||
| Q2 25 | 1.3% | 26.8% | ||
| Q1 25 | 8.5% | 7.7% | ||
| Q4 24 | -20.3% | 26.4% | ||
| Q3 24 | -10.7% | 13.7% | ||
| Q2 24 | -0.8% | 2.1% | ||
| Q1 24 | 3.6% | — |
资本支出强度DOMOPBYI
| Q4 25 | 2.9% | 0.0% | ||
| Q3 25 | 2.9% | 0.0% | ||
| Q2 25 | 3.7% | 0.0% | ||
| Q1 25 | 2.8% | 0.1% | ||
| Q4 24 | 3.2% | 0.0% | ||
| Q3 24 | 2.8% | 0.0% | ||
| Q2 24 | 3.2% | 0.0% | ||
| Q1 24 | 3.1% | 0.0% |
现金转化率DOMOPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOMO
| Subscription | $71.9M | 91% |
| Professional Servicesand Other | $7.5M | 9% |
PBYI
暂无分部数据
